Mitobronitol

Mitobronitol is a prescription medication used to reduce the risk of death from heart failure in people with certain types of heart disease. It works by blocking certain hormones that are involved in the progression of heart failure. This medicine is usually given in combination with other drugs that help reduce the symptoms of heart failure. It is used as an anticancer drug. Common side effects of Mitobronitol include headache, dizziness, fatigue, nausea, abdominal pain, diarrhea, and rash.

Mitobronitol is a medication that was once used to treat some types of cancer. It is a white powder that is insoluble in water. Mitobronitol is an alkylating agent, which means it works by damaging the DNA of cancer cells. This damage can prevent the cancer cells from growing and dividing.

Mitobronitol is no longer commonly used as a cancer treatment because there are more effective and less toxic treatments available. However, it is still sometimes used to treat a condition called polycythemia vera. Polycythemia vera is a type of blood cancer that causes the body to produce too many red blood cells.

Mitobronitol is typically given as an injection or infusion (liquid put into a vein). The most common side effects of mitobronitol include nausea, vomiting, and fatigue. Mitobronitol can also cause more serious side effects, such as bone marrow suppression and leukemia.

Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01A - Alkylating agents
L01AX Other alkylating agents
External Links